SCHEMBL31566493

SCHEMBL31566493

CC(C)(C)OC(=O)N1CC[C@@]2(CCC2=O)C1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.50
CYP11B2 P19099 1/20 0.43
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ACACB O00763 5/20 0.40
CRBN Q96SW2 3/20 0.40
DDB1 Q16531 1/20 0.40
SCD5 Q86SK9 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
NR1H2 P55055 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ESR2 Q92731 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20521260 1.00 USP30 (0.50) USP30CYP11B2USP2SMN1; SMN2ACACB
SCHEMBL31566998 1.00 USP30 (0.50) USP30CYP11B2USP2SMN1; SMN2ACACB
SCHEMBL31567024 0.91 USP30 (0.48) USP30CYP11B2USP2SMN1; SMN2ACACB
SCHEMBL31566861 0.91 USP30 (0.48) USP30CYP11B2USP2SMN1; SMN2ACACB
SCHEMBL31171576 0.91 USP30 (0.48) USP30CYP11B2USP2SMN1; SMN2ACACB
SCHEMBL5895323 0.91 USP2 (0.47) USP30USP2SMN1; SMN2CRBNDDB1
SCHEMBL31171500 0.90 USP30 (0.47) USP30CYP11B2USP2SMN1; SMN2ACACB
SCHEMBL2158895 0.89 USP30 (0.46) USP30CYP11B2USP2SMN1; SMN2ACACB
SCHEMBL20601939 0.89 USP30 (0.42) USP30CYP11B2USP2SMN1; SMN2ACACB
SCHEMBL4985158 0.87 USP30 (0.44) USP30CYP11B2USP2SMN1; SMN2ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096637-A1 SUBSTITUTED ARYL SULFONAMIDES FOR USE AS SODIUM CHANNEL INHIBITORS XENON PHARMACEUTICALS INC. (CA) 2025-05-08 WO disclosed